Company Profile

Biodexa Pharmaceuticals plc (NASDAQ: BDRX)
5:30 PM UTC, 07/03/24
Last: $0.89 Change: -0.01 %Change: -0.84% Volume: 146,975
Detailed Quote
Open: $ 0.87   Volume: 146,975
High: $ 0.91   Yield(%) 0.00
Low: $ 0.86   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 212,859.90
EPS ($) n/a   Shares Out: 236,511.00
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -12.07
% Price Change (last 13 weeks): -34.05
% Price Change (last 26 weeks): -66.66
% Price Change (last 52 weeks): -82.88
% Price Change (year to date): -66.42
Management Effectiveness
Return on Equity (%): -180.19
Return on Assets (%): -87.62
Return on Invested Capital (%): -99.74
Profitability
Gross Profit Margin (%): 25.72
Net Profit Margin (%): -1858.01
Operating Profit Margin (%): -2043.31
Price & Volume
50-day Moving Average: $1.05
200-day Moving Average: $2.20
Avg. Daily Vol. (last 50 days): 4,572,167
Avg. Daily Vol. (last 200 days): 2,019,459
52-wk high: $9.74
52-wk low: $0.67
Bid: $0.86
Ask: $0.87
Company Information
Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Biodexa Pharmaceuticals plc
1 Caspian Point Caspian Way
Cardiff CD CF10 4DQ

Phone: 44.1235.888.300
Fax: n/a
http://www.midatechpharma.com
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.38
Cash Flow ($): -2.84
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 4.47
Price/Book (x): 7.03
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.26
Current Ratio (x): 1.26
LT Debt/Equity (x): 6.31
Total Debt/Equity (x): 9.92



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.